top of page

Out to revamp plant-based drug manufacturing, Antheia locks in partnership with synthetic biology...

With supply chain shortages at the forefront of nearly every business in the world right now, whether it be chicken wings or CAR-T cell therapy, synthetic biology upstart Antheia is looking to aid in the fight. It just announced a deal with a giant in the field to help it along.

Read the article at:

bottom of page